RNA Modifications in Diabetes

This feed looks at the emerging role of epigenetic modifications, such as those that occur on RNA that may affect function in various diseases. Discover the latest research on RNA Modifications in Diabetes.

July 23, 2020
Open Access

Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitors

Therapeutic Advances in Medical Oncology
Pascal HammelCindy Neuzillet
July 23, 2020
Open Access

SARS-CoV-2 receptor Angiotensin I-Converting Enzyme type 2 is expressed in human pancreatic islet β-cells and is upregulated by inflammatory stress

BioRxiv : the Preprint Server for Biology
D. FignaniFrancesco Dotta
July 23, 2020

Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms

The Journal of Pathology
Bo HuangNicholas J Roberts
July 28, 2020
Case Report

Allograft infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant recipient

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Timm H WesthoffNina Babel
July 23, 2020
Open Access

Evaluation of different types of arsenic methylation and its relationship with metabolic syndrome in an area chronically exposed to arsenic

Environmental Analysis, Health and Toxicology
Amir Mohammad KazemifarMaryam Arami
July 31, 2020

Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease

BioRxiv : the Preprint Server for Biology
Laura J Smyth GENIE consortium
July 25, 2020
Open Access

NT3/TrkC pathway modulates the expression of UCP-1 and adipocyte size in human and murine adipose tissue

BioRxiv : the Preprint Server for Biology
M. BovePilar D'Ocon
July 28, 2020

Shenmai Injection Upregulates Heme Oxygenase-1 to Confer Protection Against Severe Acute Pancreatitis

The Journal of Surgical Research
Fei-Hu ZhangLi Kong
August 3, 2020

New Mechanisms of Vascular Dysfunction in Cardiometabolic Patients: Focus on Epigenetics

High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
Samuele AmbrosiniFrancesco Paneni
July 28, 2020
Open Access

Multi-layered epigenetic regulation of IRS2 expression in the liver of obese individuals with type 2 diabetes

Christin KrauseHenriette Kirchner
August 1, 2020
Open Access

Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease

Frontiers in Physiology
Linsey J F PetersDonato Santovito
August 2, 2020

Epigenetic measures of ageing predict the prevalence and incidence of leading causes of death and disease burden

Clinical Epigenetics
Robert F HillaryRiccardo E Marioni
July 30, 2020
Open Access

Glucagon-like peptide-1 receptor mediates the beneficial effect of Liraglutide in an acute lung injury mouse model involving the thioredoxin interacting protein

American Journal of Physiology. Endocrinology and Metabolism
Wenyong ZhouTianru Jin

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.


Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

© 2020 Meta ULC. All rights reserved